Spain's "The Economist" reported on September 2 local time that the joint statement issued by the United States Modena Company and the Agent of modena New Crown Vaccine in Japan, Takeda Company, said that the results of the investigation of the contamination of the Modena new crown vaccine produced by Spain's Rovi Pharmaceutical Company showed that the batch of vaccines contained stainless steel particles.
The results of the report submitted by Rovey Pharmaceuticals show that the most likely cause of stainless steel particles is friction caused by the metal installed in the production line due to installation errors, which affected three batches of vaccines. The pharmaceutical company has decided to take steps to avoid a recurrence of the incident, such as a comprehensive inspection and improvement of the production line. The results of the survey also showed that there was no direct evidence that the cause of death of 2 Japanese people who died after receiving the vaccine containing the impurity batch was related to the vaccine.
On August 26, local time, Japan's official statement said that due to the impurities in the vaccine, the use of about 1.63 million doses of Modena new crown vaccine will be suspended, and Spanish Rovi Pharmaceutical Company subsequently investigated the possible production accidents of three batches of Modena vaccine.
Rovi Pharmaceuticals is a strategic partner of Modena in Spain and can produce 600 million doses of Modena's COVID-19 vaccine per year during the bottling phase. (Reporter Deng Zongyu)
Source: CCTV News Client
![Bundesliga: Borussia Dort 1-1 Augsburg, Demirovic scored a controversial goal and Malen equalized[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)